Cargando…

The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis

Clinical reports on early immune dysregulation in acute pancreatitis (AP) are scarce. Herein we investigate the initial temporal development of selected biomarkers. Blood samples were taken at 0–24 and 25–48 h after onsets of AP were acquired. Mean values and temporal intermediate difference (delta-...

Descripción completa

Detalles Bibliográficos
Autores principales: Sternby, Hanna, Hartman, Hannes, Thorlacius, Henrik, Regnér, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073083/
https://www.ncbi.nlm.nih.gov/pubmed/33920566
http://dx.doi.org/10.3390/biom11040591
_version_ 1783684052062044160
author Sternby, Hanna
Hartman, Hannes
Thorlacius, Henrik
Regnér, Sara
author_facet Sternby, Hanna
Hartman, Hannes
Thorlacius, Henrik
Regnér, Sara
author_sort Sternby, Hanna
collection PubMed
description Clinical reports on early immune dysregulation in acute pancreatitis (AP) are scarce. Herein we investigate the initial temporal development of selected biomarkers. Blood samples were taken at 0–24 and 25–48 h after onsets of AP were acquired. Mean values and temporal intermediate difference (delta-values) of IL-1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α were calculated. Differences between severity groups, predictive capacity of the biomarkers and association with severe disease were analyzed. Paired comparison of samples (n = 115) taken at 0–24 and 25–48 h after onsets of AP showed a change over time for IL-1β, IL-6, IL-8 and IL-10 (p < 0.05) and a significant difference between severity groups after 24 h. In ROC-analysis an IL-6 cut-off level of 196.6 pg/mL could differentiate severe AP (sensitivity 81.9, specificity 91.3). The delta-values of IL-1β and IL-6 were significantly associated with severe outcomes (odds ratios 1.085 and 1.002, respectively). Data of this work demonstrate a distinct change in IL-1β, IL-8, IL-10 and IL-6 over the first 48 h after onset of AP. The temporal development of biomarkers can assist in the early stratification of the disease. Herein IL-1β and IL-6 were associated with severe disease, however the prognostic capacity of investigated biomarkers is low.
format Online
Article
Text
id pubmed-8073083
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80730832021-04-27 The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis Sternby, Hanna Hartman, Hannes Thorlacius, Henrik Regnér, Sara Biomolecules Article Clinical reports on early immune dysregulation in acute pancreatitis (AP) are scarce. Herein we investigate the initial temporal development of selected biomarkers. Blood samples were taken at 0–24 and 25–48 h after onsets of AP were acquired. Mean values and temporal intermediate difference (delta-values) of IL-1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α were calculated. Differences between severity groups, predictive capacity of the biomarkers and association with severe disease were analyzed. Paired comparison of samples (n = 115) taken at 0–24 and 25–48 h after onsets of AP showed a change over time for IL-1β, IL-6, IL-8 and IL-10 (p < 0.05) and a significant difference between severity groups after 24 h. In ROC-analysis an IL-6 cut-off level of 196.6 pg/mL could differentiate severe AP (sensitivity 81.9, specificity 91.3). The delta-values of IL-1β and IL-6 were significantly associated with severe outcomes (odds ratios 1.085 and 1.002, respectively). Data of this work demonstrate a distinct change in IL-1β, IL-8, IL-10 and IL-6 over the first 48 h after onset of AP. The temporal development of biomarkers can assist in the early stratification of the disease. Herein IL-1β and IL-6 were associated with severe disease, however the prognostic capacity of investigated biomarkers is low. MDPI 2021-04-17 /pmc/articles/PMC8073083/ /pubmed/33920566 http://dx.doi.org/10.3390/biom11040591 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sternby, Hanna
Hartman, Hannes
Thorlacius, Henrik
Regnér, Sara
The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis
title The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis
title_full The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis
title_fullStr The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis
title_full_unstemmed The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis
title_short The Initial Course of IL1β, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α with Regard to Severity Grade in Acute Pancreatitis
title_sort initial course of il1β, il-6, il-8, il-10, il-12, ifn-γ and tnf-α with regard to severity grade in acute pancreatitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073083/
https://www.ncbi.nlm.nih.gov/pubmed/33920566
http://dx.doi.org/10.3390/biom11040591
work_keys_str_mv AT sternbyhanna theinitialcourseofil1bil6il8il10il12ifngandtnfawithregardtoseveritygradeinacutepancreatitis
AT hartmanhannes theinitialcourseofil1bil6il8il10il12ifngandtnfawithregardtoseveritygradeinacutepancreatitis
AT thorlaciushenrik theinitialcourseofil1bil6il8il10il12ifngandtnfawithregardtoseveritygradeinacutepancreatitis
AT regnersara theinitialcourseofil1bil6il8il10il12ifngandtnfawithregardtoseveritygradeinacutepancreatitis
AT sternbyhanna initialcourseofil1bil6il8il10il12ifngandtnfawithregardtoseveritygradeinacutepancreatitis
AT hartmanhannes initialcourseofil1bil6il8il10il12ifngandtnfawithregardtoseveritygradeinacutepancreatitis
AT thorlaciushenrik initialcourseofil1bil6il8il10il12ifngandtnfawithregardtoseveritygradeinacutepancreatitis
AT regnersara initialcourseofil1bil6il8il10il12ifngandtnfawithregardtoseveritygradeinacutepancreatitis